American Healthcare REIT Inc
AHR
ISIN null / Valor 121882465
American Healthcare REIT Inc
UMushroom community rating:
About company
American Healthcare REIT Inc is a real estate investment trust that focuses on acquiring, owning, and managing a diversified portfolio of healthcare-related properties across the United States. The company primarily invests in senior housing facilities, including RIDEA (Real Estate Investment Diversification and Empowerment Act) properties, which allow for a more active role in the management and operation of these facilities. Additionally, American Healthcare REIT Inc holds interests in integrated senior health campuses, often through joint ventures, which combine residential and healthcare services to cater to the needs of senior citizens. The company's strategic approach aims to capitalize on the growing demand for healthcare services driven by an aging population, positioning itself as a key player in the healthcare real estate sector.
Summarized from source with an LLMView SourceSector: FinanceLatest Results (21.11.2025):
American Healthcare REIT, Inc. — Fourth Quarter 2024: The company reported Q4 and full‑year 2024 results showing GAAP losses but solid operating performance, driven by strong Same‑Store NOI growth and improved balance sheet metrics; management also issued full‑year 2025 guidance. Key operating and capital‑markets actions in Q4 included asset purchases and dispositions, equity raised through an ATM, and continued portfolio repositioning.
GAAP and NFFO results
Q4 2024 GAAP net loss attributable to controlling interest was $(31.8) million (GAAP net loss to common of $(0.21) per diluted share). Full‑year 2024 GAAP net loss was $(37.8) million (GAAP net loss to common of $(0.29) per diluted share). Normalized FFO (NFFO) was $0.40 per diluted share in Q4 and $1.41 per diluted share for FY 2024.
Same‑Store NOI — strong growth
Total portfolio Same‑Store NOI grew 21.6% in Q4 2024 and 17.7% for FY 2024 versus 2023. SHOP and ISHC led growth: SHOP +66.6% (Q4) and +52.8% (FY); ISHC +28.0% (Q4) and +23.8% (FY). Outpatient Medical and Triple‑Net segments showed modest increases.
Transactions & portfolio activity
During FY 2024 the company purchased over $650 million of investments (including buying out a Trilogy minority interest). In Q4 the Company acquired a 90‑unit SHOP in the Atlanta MSA for ≈$7.5 million and subsequently contracted to buy two SHOP assets for ≈$70.5 million. The firm sold ~10 properties in Q4 for ≈$120.5 million and sold ≈$155.5 million of properties during the year.
Capital markets and balance sheet
As of Dec 31, 2024 consolidated indebtedness was $1.69 billion with ≈$984.3 million of total liquidity (cash, restricted cash, undrawn capacity). The company established a $500 million ATM in November 2024; Q4 ATM sales issued 4,285,531 shares for gross proceeds ≈$120.2 million, and FY 2024 equity/ATM activity raised ≈$1.36 billion. Net‑Debt‑to‑Annualized Adjusted EBITDA improved from 8.5x (Dec 31, 2023) to 4.3x (Dec 31, 2024).
2025 guidance
Full‑year 2025 guidance: Total portfolio Same‑Store NOI growth 7.0%–10.0% (midpoint 8.5%); NFFO per diluted share $1.56–$1.60 (midpoint $1.58); NAREIT FFO $1.49–$1.53; net income per diluted share $0.26–$0.30 (midpoint $0.28). Segment guidance targets SHOP ~18%–22% and ISHC ~10%–12% SS NOI growth.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
8580 M
Market cap (USD)
1,634,403
Daily traded volume (Shares)
28.39 / 27.85
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
